Rani Therapeutics Holdings, Inc.
RANI

$80.4 M
Marketcap
$1.40
Share price
Country
$0.10
Change (1 day)
$8.75
Year High
$1.30
Year Low
Categories

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.

marketcap

Stock price history for Rani Therapeutics Holdings, Inc. (RANI)

Highest end of day price: $35.00 USD on 2021-11-18

Lowest end of day price: $1.30 USD on 2024-12-19

Stock price history of Rani Therapeutics Holdings, Inc. from 2021 to 2024